您当前的位置:
首页 >
文章列表页 >
SIRT1 agonist inhibits smooth muscle foam cell formation by decreasing ACAT1 expression
更新时间:2026-01-09
    • SIRT1 agonist inhibits smooth muscle foam cell formation by decreasing ACAT1 expression

    • Journal of Third Military Medical University   Vol. 39, Issue 9, Pages: 846-851(2017)
    • DOI:10.16016/j.1000-5404.201611076    

      CLC:
    • Received:16 November 2016,

      Published:15 May 2017

    移动端阅览

  • Xu Wang, Xue Chen, Mengjiao Sun, et al. SIRT1 agonist inhibits smooth muscle foam cell formation by decreasing ACAT1 expression[J]. Journal of Third Military Medical University, 2017, 39(9): 846-851. DOI: 10.16016/j.1000-5404.201611076.

  •  
  •  
icon
试读结束,您可以激活您的VIP账号继续阅读。
去激活 >
icon
试读结束,您可以通过登录账户,到个人中心,购买VIP会员阅读全文。
已是VIP会员?
去登录 >

0

Views

0

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

PPARδ suppresses foam cells formation from vascular smooth muscle cells by down-regulating ACAT1
Macropinocytosis mediates accumulation of lipid droplets in vascular smooth muscle cells in vitro
OxLDL promotes vascular smooth muscle cells to form foam cells through PPARγ-ABCG1 signal pathway
TLR4 promotes VSMCs-derived foam cells formation via down-regulating ABCA1 expression
Role of miR-145 expression in arterial intimal hyperplasia of hypertension in rats

Related Author

龙春燕
张莉莉
孙梦娇
黎炳护
皮燕
李敬诚
廖少琼
尹延伟

Related Institution

Department of Neurology, Institute of Surgery Research, Third Affiliated Hospital, Army Medical University (Third Military Medical University)
0